Latest news

30/10/2026

Highly Sensitive Detection of MRI Contrast Agents

Gadolinium is a component of contrast agents used in MRI examinations, which can be released into the environment through patients’ urine. Scientists at the German Cancer Research Center (DKFZ) have…

30/10/2026

New Approach Could Make Immunotherapy for Blood Cancer More Precise

Freiburg DKTK Researchers Discover a New Approach for Developing Targeted Therapies Against Aggressive T-Cell Leukemia / Modified Immune Cells Attack Cancer Cells While Sparing Important Healthy…

30/10/2026

Science meets Industry Day 2026: Strengthening Collaboration between Academia and Industry

Following its successful debut in 2025, the Science meets Industry Day returned for its second edition on October 20, 2026, in Heidelberg. Jointly organized by the German Cancer Consortium (DKTK), the…

28/10/2026

3 Questions for Amulya Sreekumar

Since June, Dr. Amulya Sreekumar has joined the DKTK partner site Berlin as DKTK Young Investigator Group Leader for "Adaptive Glycan Remodeling in Cancer Progression". We are delighted to have her on…

21/10/2026

A New Platform of Robust Patient-Derived AML Models for Translational Research

Acute myeloid leukemia (AML) is an aggressive blood cancer with a dismal prognosis. Therefore, researchers aim to identify new treatment options. However, as AML is a very heterogenic cancer, it is…

14/10/2026

How cancer cells lose their most dangerous DNA

Aggressive tumors often contain large amounts of exchromosomal DNA. Removing this DNA from the nuclei of cancer cells could improve patient outcomes, an international team led by researchers at…

09/10/2026

Awarding of the 4th Wilko Weichert Grant

The DKTK partner site Munich announces an annual call for the Wilko Weichert Grant to support an interdisciplinary project that fosters early-career researchers and involves collaboration between LMU…

07/10/2026

AI Model Aims to Significantly Simplify Blood Cancer Diagnostics

A new open-source AI model developed by the University Medical Center Freiburg automatically detects cancer cells and reduces the need for manual evaluation / Standardized analysis of routine clinical…

07/10/2026

Experiencing Science in the Lab: DKTK Researchers Turn an ISH Placement into an Ambassador Activity

As part of the DKTK Ambassador Program, the “Prevention and Liquid Biopsies” research group at German Cancer Research Center (DKFZ) and Hopp Children’s Cancer Center Heidelberg (KiTZ) hosted two…

03/10/2026

New vulnerability discovered in aggressive childhood brain tumors

Researchers at the Hopp Children’s Cancer Center in Heidelberg (KiTZ) and at St. Jude Children’s Research Hospital in Memphis have discovered a potential new vulnerability in medulloblastomas, the…

16/09/2026

Award winners for the Dresden DZG-overarching projects 2026

The mission of the German Centres for Health Research (DZG) is to promote translational research to combat common diseases. There are four DZG centres in Dresden that work on diabetes,…

09/09/2026

Quality Over Quantity: New Insights into the Role of Certain CAR-T Cells in Cancer Therapy

CAR-T cell therapies are successfully used to treat certain types of blood cancer. However, while immunotherapy is effective even at low doses for some patients, it has no effect on others.…

12/08/2026

Immune Cells in Bone Marrow Cancer: Limited Defense Readiness

A team led by researchers from the German Cancer Research Center (DKFZ), the HI-STEM* Stem Cell Institute, the Medical Clinic V at Heidelberg University Hospital (UKHD) and the German Cancer…

05/08/2026

Portal provides guidance on sharing genomic data

A new information portal, "Meine Genomdaten. Teilen und Helfen", is now available to provide clear, accessible information about the role of genomic data in medicine and research. The portal helps…

24/07/2026

4. DZG Munich Day 2026: Health Research in Munich Working Together for the Medicine of Tomorrow

Scientific highlights, transdisciplinary research, and new collaborations will be the focus of DZG Munich Day on July 29, 2026. For the fourth time, the eight German Centers for Health Research (DZG)…

22/07/2026

Early-Career Researchers Advance Translational Cancer Research in Heidelberg

The Heidelberg PostDoc Symposium 2026 and the DKTK Young Academics Conference brought together over 100 early-career researchers for a day of scientific exchange at the German Cancer Research Center…

22/07/2026

3 Questions for Florian Ingelfinger

Since April, Dr. Florian Ingelfinger has joined the DKTK partner site Freiburg as DKTK Young Investigator Group Leader for "Generative Single Cell Immunology". We are delighted to have him on board…

10/07/2026

DKFZ Innovation Award and DKFZ Patient Expert Award Presented

The Friends of the German Cancer Research Center (DKFZ) support the DKFZ and aim to help strengthen its position in the international arena. With the DKFZ Innovation Award, presented at this year’s…

08/07/2026

B-cell lymphoma: Cause of high-risk disease discovered

Researchers led by Universitätsmedizin Frankfurt and Goethe University Frankfurt, partner site Frankfurt/Mainz of the German Cancer Consortium (DKTK), have identified how particularly aggressive forms…

08/07/2026

Vaccine Against Brain Tumors Shows Promising Long-Term Results

A novel vaccination strategy against certain malignant brain tumors could fundamentally improve treatment for patients. Researchers from the German Cancer Research Center (DKFZ), Mannheim University…